NCT05723081 Oklahoma Study of Native American Pain Risk III: Stress and Resilience
| NCT ID | NCT05723081 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Discrimination, Racial |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2023-02-03 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2023-02-03 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the relationship between environmental structural racism and discrimination and chronic pain risk in Native American adults. The main questions it aims to answer are: 1. How does environmental structural racism and discrimination affect chronic pain-promoting mechanisms in Native Americans? 2. What psychosocial factors buffer the negative effects of environmental structural racism and discrimination on chronic pain-promoting mechanisms?
Eligibility Criteria
Inclusion Criteria: * Self-identify as Native American/American Indian Exclusion Criteria: * \<18 years of age * Self-reported history of cardiovascular, neuroendocrine, musculoskeletal, or neurological disorders * Surrent chronic pain, defined as persistent, bothersome pain on more days than not for at least 3 months) * Self-reported current substance dependence * Sse of medication that could interfere with testing (e.g., recent use of analgesics, antidepressants, or anti-anxiety medications) * Inability to speak English * Current psychosis (assessed by Psychosis Screening Questionnaire) * Serious cognitive impairment (assessed by \<20 score on the Montreal Cognitive Assessment \[MoCA\]) * Possible peripheral neuropathy (assessed by nerve conduction study)
Contact & Investigator
Jamie L Rhudy, PhD
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT05723081 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Discrimination, Racial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05723081 currently recruiting?
Yes, NCT05723081 is actively recruiting participants. Contact the research team at tulsa.plan@gmail.com for enrollment information.
Where is the NCT05723081 trial being conducted?
This trial is being conducted at Tulsa, United States.
Who is sponsoring the NCT05723081 clinical trial?
NCT05723081 is sponsored by University of Oklahoma. The principal investigator is Jamie L Rhudy, PhD at University of Oklahoma. The trial plans to enroll 220 participants.